Intervention Review

Propylthiouracil for alcoholic liver disease

  1. Giuseppe Fede1,
  2. Giacomo Germani1,
  3. Christian Gluud2,
  4. Kurinchi Selvan Gurusamy3,
  5. Andrew K Burroughs1,*

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 15 JUN 2011

Assessed as up-to-date: 3 MAY 2010

DOI: 10.1002/14651858.CD002800.pub3

How to Cite

Fede G, Germani G, Gluud C, Gurusamy KS, Burroughs AK. Propylthiouracil for alcoholic liver disease. Cochrane Database of Systematic Reviews 2011, Issue 6. Art. No.: CD002800. DOI: 10.1002/14651858.CD002800.pub3.

Author Information

  1. 1

    Royal Free Hampstead NHS Foundation Trust, Sheila Sherlock Liver Centre, London, UK

  2. 2

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

  3. 3

    Royal Free Campus, UCL Medical School, Department of Surgery, London, UK

*Andrew K Burroughs, Sheila Sherlock Liver Centre, Royal Free Hampstead NHS Foundation Trust, Pond Street, Hampstead, London, NW3 2QG, UK.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 15 JUN 2011


Cited in:


This article has been cited by:

  1. 1
    Eric S Orman, Gemma Odena, Ramon Bataller, Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy, Journal of Gastroenterology and Hepatology, 2013, 28,
  2. 2
    Bin Gao, Ramon Bataller, Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets, Gastroenterology, 2011, 141, 5, 1572


  3. 3
    Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Douglas Thorburn, Brian R Davidson, Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): a network meta-analysis, The Cochrane Library,